BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 37625556)

  • 1. Inhibition of STAT-mediated cytokine responses to chemically-induced colitis prevents inflammation-associated neurobehavioral impairments.
    Sin R; Sotogaku N; Ohnishi YN; Shuto T; Kuroiwa M; Kawahara Y; Sugiyama K; Murakami Y; Kanai M; Funakoshi H; Chakraborti A; Bibb JA; Nishi A
    Brain Behav Immun; 2023 Nov; 114():173-186. PubMed ID: 37625556
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DSS-induced colitis activates the kynurenine pathway in serum and brain by affecting IDO-1 and gut microbiota.
    Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Li T; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
    Front Immunol; 2022; 13():1089200. PubMed ID: 36776388
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inflammation and serotonin deficiency in major depressive disorder: molecular docking of antidepressant and anti-inflammatory drugs to tryptophan and indoleamine 2,3-dioxygenases.
    Dawood S; Bano S; Badawy AA
    Biosci Rep; 2022 May; 42(5):. PubMed ID: 35506370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tryptophan kynurenine metabolism as a common mediator of genetic and environmental impacts in major depressive disorder: the serotonin hypothesis revisited 40 years later.
    Oxenkrug GF
    Isr J Psychiatry Relat Sci; 2010; 47(1):56-63. PubMed ID: 20686200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracerebroventricular Administration of Streptozotocin as an Experimental Approach to Depression: Evidence for the Involvement of Proinflammatory Cytokines and Indoleamine-2,3-Dioxygenase.
    Souza LC; Jesse CR; de Gomes MG; Viana CE; Mattos E; Silva NC; Boeira SP
    Neurotox Res; 2017 May; 31(4):464-477. PubMed ID: 28155213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DSS-induced acute colitis causes dysregulated tryptophan metabolism in brain: an involvement of gut microbiota.
    Zhao LP; Wu J; Quan W; Zhou Y; Hong H; Niu GY; Ting-Li ; Huang SB; Qiao CM; Zhao WJ; Cui C; Shen YQ
    J Nutr Biochem; 2023 May; 115():109282. PubMed ID: 36758839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of IDO1 and TDO2 inhibition on cognitive deficits and anxiety following LPS-induced neuroinflammation.
    Imbeault S; Goiny M; Liu X; Erhardt S
    Acta Neuropsychiatr; 2020 Feb; 32(1):43-53. PubMed ID: 31753057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade of IDO-Kynurenine-AhR Axis Ameliorated Colitis-Associated Colon Cancer via Inhibiting Immune Tolerance.
    Zhang X; Liu X; Zhou W; Du Q; Yang M; Ding Y; Hu R
    Cell Mol Gastroenterol Hepatol; 2021; 12(4):1179-1199. PubMed ID: 34087454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tryptophan 2,3-dioxygenase, a novel therapeutic target for Parkinson's disease.
    Boros FA; Vécsei L
    Expert Opin Ther Targets; 2021 Oct; 25(10):877-888. PubMed ID: 34720020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interleukin-6 promotes skeletal muscle catabolism by activating tryptophan-indoleamine 2,3-dioxygenase 1-kynurenine pathway during intra-abdominal sepsis.
    Xie T; Lv T; Zhang T; Feng D; Zhu F; Xu Y; Zhang L; Gu L; Guo Z; Ding C; Gong J
    J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):1046-1059. PubMed ID: 36880228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipopolysaccharide-induced brain activation of the indoleamine 2,3-dioxygenase and depressive-like behavior are impaired in a mouse model of metabolic syndrome.
    Dinel AL; André C; Aubert A; Ferreira G; Layé S; Castanon N
    Psychoneuroendocrinology; 2014 Feb; 40():48-59. PubMed ID: 24485475
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-β1-42 peptide in mice.
    Souza LC; Jesse CR; Antunes MS; Ruff JR; de Oliveira Espinosa D; Gomes NS; Donato F; Giacomeli R; Boeira SP
    Brain Behav Immun; 2016 Aug; 56():363-77. PubMed ID: 26965653
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NFκB-dependent increase of kynurenine pathway activity in human placenta: inhibition by sulfasalazine.
    Dharane Neé Ligam P; Manuelpillai U; Wallace E; Walker DW
    Placenta; 2010 Nov; 31(11):997-1002. PubMed ID: 20884048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
    Kim M; Tomek P
    Front Immunol; 2021; 12():636081. PubMed ID: 33708223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
    Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
    Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kynurenine Is the Main Metabolite of Tryptophan Degradation by Tryptophan 2,3-Dioxygenase in HepG2 Tumor Cells.
    Oweira H; Lahdou I; Mehrle S; Khajeh E; Nikbakhsh R; Ghamarnejad O; Terness P; Reißfelder C; Sadeghi M; Ramouz A
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36013032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy.
    Kang A; Hao H; Zheng X; Liang Y; Xie Y; Xie T; Dai C; Zhao Q; Wu X; Xie L; Wang G
    J Neuroinflammation; 2011 Aug; 8():100. PubMed ID: 21843370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of water-immersion restraint stress on tryptophan catabolism through the kynurenine pathway in rat tissues.
    Ohta Y; Kubo H; Yashiro K; Ohashi K; Tsuzuki Y; Wada N; Yamamoto Y; Saito K
    J Physiol Sci; 2017 May; 67(3):361-372. PubMed ID: 27364617
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patchouli alcohol ameliorates dextran sodium sulfate-induced experimental colitis and suppresses tryptophan catabolism.
    Qu C; Yuan ZW; Yu XT; Huang YF; Yang GH; Chen JN; Lai XP; Su ZR; Zeng HF; Xie Y; Zhang XJ
    Pharmacol Res; 2017 Jul; 121():70-82. PubMed ID: 28456683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IDO/Kynurenine; novel insight for treatment of inflammatory diseases.
    Lashgari NA; Roudsari NM; Shayan M; Niazi Shahraki F; Hosseini Y; Momtaz S; Abdolghaffari AH
    Cytokine; 2023 Jun; 166():156206. PubMed ID: 37120946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.